Wellington Management Group LLP Raises Stock Holdings in Legend Biotech Co.
LEGN Stock | USD 34.63 1.15 3.43% |
About 55% of Legend Biotech's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Legend Biotech Corp suggests that some traders are interested. Legend Biotech's investing sentiment overview a quick insight into current market opportunities from investing in Legend Biotech Corp. Many technical investors use Legend Biotech Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Wellington Management Group LLP boosted its holdings in Legend Biotech Co. by 4.1 percent in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 2,120,775 shares of the companys stock after acquiring an additional 84,405 shares during the period. Wellington Management Group LLPs holdings in Legend Biotech were worth 69,010,000 as
Read at thelincolnianonline.com
![]() |
Legend Biotech Fundamental Analysis
We analyze Legend Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Legend Biotech is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Legend Biotech Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Legend Biotech stock to make a market-neutral strategy. Peer analysis of Legend Biotech could also be used in its relative valuation, which is a method of valuing Legend Biotech by comparing valuation metrics with similar companies.
Peers
Legend Biotech Related Equities
ALNY | Alnylam Pharmaceuticals | 1.44 | ||||
ACLX | Arcellx | 0.90 | ||||
MDGL | Madrigal Pharmaceuticals | 0.41 | ||||
BPMC | Blueprint Medicines | 0.03 | ||||
DAWN | Day One | 0.15 | ||||
AKRO | Akero Therapeutics | 0.16 | ||||
ASND | Ascendis Pharma | 0.42 | ||||
ETNB | 89bio | 0.90 | ||||
PCVX | Vaxcyte | 0.91 | ||||
STOK | Stoke Therapeutics | 1.77 | ||||
TVTX | Travere Therapeutics | 2.38 | ||||
AMLX | Amylyx Pharmaceuticals | 2.62 | ||||
PLRX | Pliant Therapeutics | 3.85 | ||||
ZLAB | Zai Lab | 4.01 | ||||
TERN | Terns Pharmaceuticals | 4.25 | ||||
APLS | Apellis Pharmaceuticals | 5.27 |
Check out Legend Biotech Hype Analysis, Legend Biotech Correlation and Legend Biotech Performance. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.